Jacqueline Flynn
Jacqueline Flynn
Verified email at monash.edu
TitleCited byYear
Oncolytic virus and anti–4-1BB combination therapy elicits strong antitumor immunity against established cancer
LB John, LJ Howland, JK Flynn, AC West, C Devaud, CP Duong, ...
Cancer research 72 (7), 1651-1660, 2012
Is the central nervous system a reservoir of HIV-1?
LR Gray, M Roche, JK Flynn, SL Wesselingh, PR Gorry, MJ Churchill
Current Opinion in HIV and AIDS 9 (6), 552, 2014
Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy
C Devaud, JA Westwood, LB John, JK Flynn, S Paquet-Fifield, ...
Molecular Therapy 22 (1), 18-27, 2014
A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations
M Roche, H Salimi, R Duncan, BL Wilkinson, K Chikere, MS Moore, ...
Retrovirology 10 (1), 43, 2013
Early IL‐10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users
JK Flynn, GJ Dore, M Hellard, B Yeung, WD Rawlinson, PA White, ...
Journal of viral hepatitis 18 (8), 549-561, 2011
Stem memory T cells (TSCM)—their role in cancer and HIV immunotherapies
JK Flynn, PR Gorry
Clinical & translational immunology 3 (7), e20, 2014
Longitudinal analysis of CCR5 and CXCR4 usage in a cohort of antiretroviral therapy-naive subjects with progressive HIV-1 subtype C infection
MR Jakobsen, K Cashin, M Roche, J Sterjovski, A Ellett, K Borm, J Flynn, ...
PloS one 8 (6), 2013
The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets
JK Flynn, G Paukovics, MS Moore, A Ellett, LR Gray, R Duncan, H Salimi, ...
Virology 442 (1), 51-58, 2013
Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4+T-cell subsets, including stem cell memory T-cells
K Cashin, G Paukovics, MR Jakobsen, L Østergaard, MJ Churchill, ...
Retrovirology 11 (1), 97, 2014
Impaired Hepatitis C Virus (HCV)–Specific Interferon-γ Responses in Individuals With HIV Who Acquire HCV Infection: Correlation With CD4+ T-Cell Counts
JK Flynn, GJ Dore, G Matthews, M Hellard, B Yeung, WD Rawlinson, ...
The Journal of infectious diseases 206 (10), 1568-1576, 2012
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strains
JK Flynn, G Paukovics, K Cashin, K Borm, A Ellett, M Roche, ...
Viruses 6 (2), 709-726, 2014
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infection
K Cashin, MR Jakobsen, J Sterjovski, M Roche, A Ellett, JK Flynn, K Borm, ...
Retrovirology 10 (1), 98, 2013
Onset of immunity in salmonids vaccinated by direct immersion with Yersinia ruckeri and Vibrio anguillarum bacterins
KA Johnson, JK Flynn, DF Amend
Journal of Fish Diseases 5, 197-205, 1982
Maintenance of T h1 hepatitis C virus (HCV)‐specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment
JK Flynn, GJ Dore, M Hellard, B Yeung, WD Rawlinson, PA White, ...
Journal of gastroenterology and hepatology 28 (11), 1770-1781, 2013
Molecular gymnastics: mechanisms of HIV-1 resistance to CCR5 antagonists and impact on virus phenotypes
M Roche, K Borm, J K Flynn, S R Lewin, M J Churchill, P R Gorry
Current topics in medicinal chemistry 16 (10), 1091-1106, 2016
Analysis of clinical HIV-1 strains with resistance to maraviroc reveals strain-specific resistance mutations, variable degrees of resistance, and minimal cross-resistance to …
JK Flynn, P Ellenberg, R Duncan, A Ellett, J Zhou, J Sterjovski, K Cashin, ...
AIDS research and human retroviruses 33 (12), 1220-1235, 2017
Detection of HCV-specific IFN-γ responses in HCV antibody and HCV RNA negative injecting drug users
JK Flynn, R Sacks-Davis, P Higgs, C Aitken, S Moneer, V Suppiah, ...
Hepatitis monthly 14 (1), 2014
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc
K Borm, MR Jakobsen, K Cashin, JK Flynn, P Ellenberg, L Ostergaard, ...
Retrovirology 13 (1), 74, 2016
T cell therapies—are T memory stem cells the answer?
JK Flynn, PR Gorry
Annals of translational medicine 3 (17), 2015
Role of macrophages in the immunopathogenesis of HIV-1 infection
JK Flynn, PR Gorry
Global Virology I-Identifying and Investigating Viral Diseases, 723-744, 2015
The system can't perform the operation now. Try again later.
Articles 1–20